Archive for the ‘Personalized Medicine’ Category

The personalized medicine project and improving user interfaces for clinicians and patients
Dr. Dieter Wallach, the managing director of Ergosign discusses the collaboration between Ergosign and p-medicine in creating user interfaces for clinicians and patients. He also talks about...

By: ecancer medicalscience

The rest is here:
The personalized medicine project and improving user interfaces for clinicians and patients - Video

The Personalized Medicine project and the Trial Outline Builder tool
Prof. Yuzuru Tanaka, a professor of the Department of Computer Science in Hokkaido University talks about his role in the Personalized Medicine project helpi...

By: ecancer medicalscience

Go here to see the original:
The Personalized Medicine project and the Trial Outline Builder tool - Video

The Personalized Medicine project and the Clinical Decision Support tool
Dr. Anca Bucur of Royal Philips Electronics of the Netherlands discusses Philips involvement in the Personalized Medicine project in helping create the Clini...

By: ecancer medicalscience

See the rest here:
The Personalized Medicine project and the Clinical Decision Support tool - Video

The Personalized Medicine project: How semantic interoperability will improve treating patients
David Perez-Rey discusses his involvement with semantic interoperability and data model issues in the Personalized Medicine project, the main differences tha...

By: ecancer medicalscience

Read more:
The Personalized Medicine project: How semantic interoperability will improve treating patients - Video

Big Data in Healthcare - Saving Lives with Personalized Medicine
In this video, Intel Fellow Eric Dishman shares his personal story of how his 25 year struggle with kidney cancer was finally resolved through Big Data and p...

By: RichReport

Read the original:
Big Data in Healthcare - Saving Lives with Personalized Medicine - Video

Personalized Medicine: Collaboration Fosters New Discoveries in the Lab and Treatments for Patients
The unveiling of the complete sequence of the human genome is providing exciting new insights into human biology and disease - discoveries that will translat...

By: schoolofmedicine

See more here:
Personalized Medicine: Collaboration Fosters New Discoveries in the Lab and Treatments for Patients - Video

Abhishek Narain Singh, Bioinformatics Component in Personalized Medicine, BioComp #39;13, USA
Abhishek Narain Singh, Bioinformatics Component in Personalized Medicine, BIOCOMP #39;13, The 14th International Conference on Bioinformatics and Computational B...

By: abynarainsingh

Read the rest here:
Abhishek Narain Singh, Bioinformatics Component in Personalized Medicine, BioComp'13, USA - Video

2013-07-17: Incorporating Personalized Medicine in Community Hospital Systems
by Jean-Claude Marshall Slideshare: http://goo.gl/dy0CN.

By: BaltimoreLeanStartup

See the original post here:
2013-07-17: Incorporating Personalized Medicine in Community Hospital Systems - Video

Start Your DNA Story (Personalized Medicine)
Discover how personalized medicine can improve your health. Contact us or your doctor for more information. naturalmolecular.com.

By: NaturalMolecular

Read more from the original source:
Start Your DNA Story (Personalized Medicine) - Video

Personalized Medicine and Cancer Genomics
cancer,lung cancer,pancreatic cancer,prostate cancer,skin cancer,what is cancer,cancer treatment,cancers,about cancer,alzheimer,alzheimers,what is alzheimer,...

By: Teknologies Tv

The rest is here:
Personalized Medicine and Cancer Genomics - Video

Personalized Medicine Coalition: How medical progress happens
Learn more about how medical progress happens from the Personalized Medicine Coalition.

By: personalizedmedicine

Read more from the original source:
Personalized Medicine Coalition: How medical progress happens - Video

Dr. Kristine Burke discusses her passion for personalized medicine
Dr. Kristine Burke talks about her unique style of practice as an n1Health physician, and her passion for providing individualized preventive care.

By: n1Health

Read this article:
Dr. Kristine Burke discusses her passion for personalized medicine - Video

Angelia Jolie is good for personalized medicine
I created this video with the YouTube Video Editor (http://www.youtube.com/editor)

By: Mallory McMed

Read more from the original source:
Angelia Jolie is good for personalized medicine - Video

19. From Genes to Personalized Medicine: Innovations in Bladder Cancer Research - Chin - LA
Arnold Chin, MD, PhD, UCLA LA Patient Forum.

By: Bladder Cancer Advocacy Network

The rest is here:
19. From Genes to Personalized Medicine: Innovations in Bladder Cancer Research - Chin - LA - Video

Natural Molecular Testing Canada: Benefits of Personalized Medicine
Testing done by NMT provides physicians with the state of the art tool that gives them data to help them understand which medications and therapies are worki...

By: NMTCanadaLtd

See the original post here:
Natural Molecular Testing Canada: Benefits of Personalized Medicine - Video

Personalized Medicine, Heredity Ethical Debate -- an excerpt from a book by Francis Collins
An excerpt from the audiobook "The Language of God: A Scientist Presents Evidence for Belief" (2006) by physician-geneticist Francis Collins (appendix sectio...

By: Byenia

Read more from the original source:
Personalized Medicine, Heredity

GM5: Mission Health Personalized Medicine and Pharmacogenomics, Asheville, NC - Lynn Dressler
May 28-29, 2013 - Genomic Medicine Centers Meeting V: Working With Federal Stakeholders. More: http://www.genome.gov/27553865.

By: GenomeTV

See the rest here:
GM5: Mission Health Personalized Medicine and Pharmacogenomics, Asheville, NC - Lynn Dressler - Video

GM5: European Science Foundation #39;s Personalized Medicine Launch Event- Dan Roden
May 28-29, 2013 - Genomic Medicine Centers Meeting V: Working With Federal Stakeholders. More: http://www.genome.gov/27553865.

By: GenomeTV

See original here:
GM5: European Science Foundation's Personalized Medicine Launch Event- Dan Roden - Video

PM 2.0 - An Integrated Approach to True Personalized Medicine Adoption
A webinar from Diaceutics on an Integrated Approach to True Personalized Medicine Adoption.

By: DiaceuticsLabceutics

Read more:
PM 2.0 - An Integrated Approach to True Personalized Medicine Adoption - Video

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 11, 2013) - During the opening of the Personalized Medicine and Individualized Drug Delivery conference at the University of British Columbia today, the $50,000 Ronnie Miller Scholarship in Personalized Medicine was presented to a deserving student studying life sciences at the University. Mr. Ronnie Miller, past Chair of the Rx&D Board (2011) and President and CEO, Hoffmann-La Roche Limited, Dr. Roger Brownsey, Department Head, Biochemistry & Molecular Biology, Dr. Pieter Cullis, Professor, Biochemistry and Molecular Biology, and Mr. John Willow, Regional Director for British Columbia, Canada's Research-Based Pharmaceutical Companies (Rx&D) were on hand for the presentation.

"My colleagues and I in the Department of Biochemistry and Molecular Biology and the Faculty of Medicine at UBC are extremely grateful to Rx&D and Hoffmann-La Roche for their wonderful act of generosity and foresight in making this donation. The support of young trainees is critical and yet remains a continuing challenge. Providing such support for one of our brightest young scientists will pay huge dividends in the future and is one of the best investments we can make," said Dr. Brownsey.

The Scholarship was awarded to Joslyn Quick, who is focusing her work on the treatment of advanced prostate cancer in the hopes that treatments eventually be tailored to a patient's own genetic profile.

The Ronnie Miller Scholarship in Personalized Medicine has been created in honour of Mr. Ronnie Miller, past Chair of the Rx&D Board (2011) and President & CEO, Hoffmann-La Roche Limited. It was awarded to a graduate student of the Department of Biochemistry and Molecular Biology at the University of British Columbia, whose work will provide a significant contribution to the British Columbia Personalized Medicine Initiative (BCPMI). Rx&D and Hoffmann-La Roche Limited have each contributed $25,000, for a total of $50,000 over 5 years.

"I am very proud of this scholarship program, and am excited by what the next generation of scientists will do to further advance personalized healthcare," added Mr. Miller. "At Roche, personalized healthcare is about improving understanding of the disease and the patient to deliver precision medicine. It is about the right treatment at the right time for the right patient. To us, it means using the combined strength of our pharmaceutical and diagnostics arms to deliver better diagnosis, better treatments and, most importantly, better results."

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies which invest more than $1 billion in research and development each year to fuel Canada's knowledge-based economy, contributing over $3 billion to the Canadian economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

Read the original here:
Scholarship in Personalized Medicine Awarded at the University of British Columbia

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/gfvrg9/personalized) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to their offering.

Personalized Medicine is often defined as the right treatment for the right person at the right time. Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industry.

Key Trends

By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.

By Diseases Segment - Personalized Medicine diagnostics market is expected to be more than US$ 30 Billion by 2018. Diabetes management test and Cancer management test are the leading market in this segment.

Renub Research report entitled Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market.

Key Topics Covered

1. Executive Summary

2. Worldwide Personalized Medicine Diagnostic Market & Forecast

Here is the original post:
Research and Markets: Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation ...

NEW YORK, June 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Personalized Medicine Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment http://www.reportlinker.com/p01361264/Personalized-Medicine-Market---A-Strategic-Analysis-of-Industry-Trends-Technologies-Participants-and-Environment.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 239 tables & figures.

The personalized medicine (global) market is presented as follows:

By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)

A wealth of financial data & business strategy information is provided including:

Up-to-date company financials, sales & revenue figures Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies Business Model Strategies for Providers. Provider Systems and Academic Medical Centres Business Model Strategies for Payers & Governments Private and Public Funding and Personalized Medicine Reimbursement Revisions to Current Payment Systems and intellectual property How to Gain Market Penetration in the EU Cost-effectiveness and Business Value of Personalized Medicine Consumer genomics and POC market Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations) Comprehensive account of company product portfolios & kits

SWOT, Economic & Regulatory Environment specifics include:

Key strengths, weaknesses and threats influencing leading player position within the market Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing) Top fastest growing market segments and emerging opportunities Top pharmaceutical companies within the IPM by market share and revenue Comprehensive product portfolios, R&D activity and pipeline therapeutics M&A activity and future strategies of top personalized medicine pharmacos Personalized Medicine Regulation (UK, Germany, France, Spain, Italy) CE-marked Personalized Medicine/Diagnostic Tests FDA Advances in Personalized Medicine Regulation

This report highlights a number of significant Indian pharmacos and gives details of their operations, products, financials and business strategy.

Excerpt from:
Personalized Medicine Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

Sino-Dutch Centre for Preventive and Personalized Medicine
The Sino-Dutch Centre for Preventive and Personalized Medicine (SD PPM) bridges the different philosophies underlying Western and Chinese medicine. In this v...

By: metabolomicsmedia

Link:
Sino-Dutch Centre for Preventive and Personalized Medicine - Video

IT #39;IS for Health: Advanced Research for Personalized Medicine
The advent of personalized medicine will redefine the future of healthcare by improving treatment efficacy and outcomes, and reducing the therapeutic burden....

By: ITISFoundation

See the article here:
IT'IS for Health: Advanced Research for Personalized Medicine - Video

TEDxUConn 2013-The Personal Side of Personalized Medicine-Christine Doherty

By: christine doherty

Follow this link:
TEDxUConn 2013-The Personal Side of Personalized Medicine-Christine Doherty - Video